AA pretreatment of healthy donor-derived CD8+ T cells led to a 3.8-fold increase in their cytotoxic activity against lymphoma cells, as measured with the LDH (lactate dehydrogenase) cytotoxicity assay (P = 0.022; Fig. 2D). Here, CD8A is linked to lymphoma.